Matthew Beyersdorf assists the Biotechnology Group in patent drafting, patent prosecution, due diligence support, IP portfolio management, and freedom-to-operate searching in the areas of molecular and cellular biology, drug development, and genetics. He has extensive knowledge in the areas of protein biochemistry, drug discovery, chemistry of natural products and transcriptional mechanisms of metastatic cancer.

Prior to joining Wolf Greenfield, Matthew earned a doctorate in Chemical Biology at the University of Michigan where his thesis research centered on the discovery of natural products and organic small molecules that modulate transcriptional protein-protein interactions involved in cancer progression. Matthew was responsible for work that led to four high-impact academic publications under preparation for submission, including two first-author manuscripts.

Additionally, Matthew was a Project Manager and the Director of Public Relations at miLEAD Consulting Group, a non-profit consulting firm that provides short-term services to scientists and technology companies in Southeast Michigan.

  • American Chemical Society
  • US Dept. of Education GAANN Fellow, University of Michigan



Scientific Publications


Lookadoo DB, Beyersdorf MS, Halkides CJ. Synthesis of a Stable Analog of the Phosphorylated Form of CheY: Phosphono-CheY. Methods in Molecular Biology 2018;1729:337-343.

Beyersdorf MS, Sircar R, Lookadoo DB, Bottone CJ, Lynch MJ, Crane BR, Halkides CJ. Production, characterization, and assessment of a stable analog of the response regulator CheY-phosphate from Thermotoga maritima. Protein Science. 2017 Aug;26(8):1547-1554.

Sircar R, Borbat PP, Lynch MJ, Bhatnagar J, Beyersdorf MS, Halkides CJ, Freed JH, Crane BR. Assembly states of FliM and FliG within the flagellar switch complex. J. Molecular Biology 2015 Feb 27;427(4):867-86.



Matt is an avid runner, hiker and kayaker.
Expand All
Matthew Beyersdorf assists the Biotechnology Group in patent drafting, patent prosecution, due diligence support, IP portfolio management, and freedom-to-operate searching in the areas of molecular and cellular biology, drug development, and genetics. He has extensive knowledge in the areas of protein biochemistry, drug discovery, chemistry of natural products and transcriptional mechanisms of metastatic cancer.

Prior to joining Wolf Greenfield, Matthew earned a doctorate in Chemical Biology at the University of Michigan where his thesis research centered on the discovery of natural products and organic small molecules that modulate transcriptional protein-protein interactions involved in cancer progression. Matthew was responsible for work that led to four high-impact academic publications under preparation for submission, including two first-author manuscripts.

Additionally, Matthew was a Project Manager and the Director of Public Relations at miLEAD Consulting Group, a non-profit consulting firm that provides short-term services to scientists and technology companies in Southeast Michigan.

  • American Chemical Society
  • US Dept. of Education GAANN Fellow, University of Michigan

Scientific Publications


Lookadoo DB, Beyersdorf MS, Halkides CJ. Synthesis of a Stable Analog of the Phosphorylated Form of CheY: Phosphono-CheY. Methods in Molecular Biology 2018;1729:337-343.

Beyersdorf MS, Sircar R, Lookadoo DB, Bottone CJ, Lynch MJ, Crane BR, Halkides CJ. Production, characterization, and assessment of a stable analog of the response regulator CheY-phosphate from Thermotoga maritima. Protein Science. 2017 Aug;26(8):1547-1554.

Sircar R, Borbat PP, Lynch MJ, Bhatnagar J, Beyersdorf MS, Halkides CJ, Freed JH, Crane BR. Assembly states of FliM and FliG within the flagellar switch complex. J. Molecular Biology 2015 Feb 27;427(4):867-86.




Matt is an avid runner, hiker and kayaker.